A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC 3rd, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC.
Chintakuntlawar AV, et al. Among authors: hilger c.
Thyroid. 2019 Nov;29(11):1615-1622. doi: 10.1089/thy.2019.0086.
Thyroid. 2019.
PMID: 31595822
Clinical Trial.